TBPH R&D Expense Growth
Theravance Biopharma Inc · R&D Expense Growth
TBPH R&D Expense Growth
Latest reported-1.67%period ending
TBPH FY R&D Growth (YoY) (0.00% → -1.67%)
Latest values, visible window
High-resolution chart · PNG
TBPH r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -1.6715% | |
| -17.8966% | |
| -33.8642% | |
| -65.2321% | |
| -22.7646% | |
| 19.0218% | |
| 8.8901% | |
| 15.7924% | |
| 22.7045% | |
| 9.7139% | |
| -23.3542% | |
| 39.7607% | |
| 5.7757% | |
| 15.3212% | |
| 0% |